Fulminant Type 1 Diabetes Mellitus With Concomitant Coxsackievirus <scp>B6</scp> Antibody Elevation and <scp>RNA</scp> ‐Based <scp>COVID</scp> ‐19 Vaccination: A Case Report and Review of the Literature
Fulminant type 1 diabetes is a rare but severe condition that can develop rapidly, often in association with viral infections. In this case, coxsackievirus B6 antibody levels were elevated after disease onset, though its significance remains unclear. This highlights the importance of thorough viral screening in fulminant type 1 diabetes and the need for further research to better understand potential contributing factors, including in post-vaccination contexts.
Authors
- Hisaka Minami
- Naozumi Shibata (ORCID: https://orcid.org/0000-0001-9997-104X)
- Yoichi Hiasa (ORCID: https://orcid.org/0000-0003-4117-339X)
- Teruki Miyake (ORCID: https://orcid.org/0000-0002-9905-5356)
- Kensuke Nagamatsu
- Shinya Furukawa (ORCID: https://orcid.org/0000-0002-0041-7688)
- Masayuki Nakaishi
- Hiroka Yamago
- KEISHO KUROKAWA
- Bunzo Matsuura (ORCID: https://orcid.org/0000-0001-7815-2512)
- Yasuhiro Sasaki (ORCID: https://orcid.org/0000-0001-7039-4250)
Institutions
- Yawata Medical Center (JP)
- Ehime University (JP)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/ccr3.70429
- Citations
- 1
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.82